The Patent Finder

Terms ending in 2034

Abbott Cardiovascular Systems, Inc.

Every in-force patent on Abbott Cardiovascular Systems, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,220,759Treatment of Diabetic Patients with a Drug Eluting Stent and Adjunctive Therapy
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 10,675,164Catheter Having Dual Balloon Hydraulic Actuator
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 9,199,408Uniform Crimping and Deployment Methods for Polymer Scaffold
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 9,744,058Methods of treatment directed to neointimal proliferation generated by endothelial shear stress patterns from drug-eluting bioresorbable vascular scaffold implantation
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 10,098,764Polymeric Stent with Structural Radiopaque Marker
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 9,138,214Suture Securing Systems, Devices and Methods
In force
 · High confidence
Abbott Cardiovascular Systems, Inc.In forceHigh confidence
US 10,327,932Catheter Having Hydraulic Actuator and Locking System
In force
 · Low confidence
Abbott Cardiovascular Systems Inc.In forceLow confidence
US 9,662,231Polymer Scaffolds Having Enhanced Axial Fatigue Properties
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 9,474,834Stent with Albumin Coating for Enhanced Thromboresistance
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
US 9,193,987Method for Thrombogenicity Testing of Implanted Medical Device
In force
 · High confidence
Abbott Cardiovascular Systems Inc.In forceHigh confidence
29 more term ends in 2034 · Pro
10 of 39 patents shown. Soonest term end first, then patent number.
Pro members see all 39.
Upgrade to Pro
37 of these are in force and held by Abbott Cardiovascular Systems, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited